{"database": "lobbying", "table": "lobbying_activities", "rows": [[1183664, "46d7b187-a427-44d5-8b15-8b01393c8be5", "Q4", "RYAN MACKINNON VASAPOLI AND BERZOK, LLP", 30187, "GENENTECH", 2011, "fourth_quarter", "MMM", "Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus. Issues relating to comparative effectiveness and CMS coverage of FDA approved therapies. Issues related to the PPS rule involving stroke guidelines. Proposals to reduce Medicare payment for Part B biologics.", "Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2012-01-11T14:57:07-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1183664"], "units": {}, "query_ms": 0.34096394665539265, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}